Back to Agenda
Session 4: Safety and Pharmacovigilance
Session Chair(s)
Sean Burke, MSc
(EFPIA IPVG Representative) Pharmacovigilance Lead, EEMEA
Merck , United Kingdom
Rachida Soulaymani-Benchei
Director
Centre Anti Poison Et De Pharmacovigilance Du Maroc, WHO Collaborative Center, Morocco
• WHO 3S Initiative and Continental Working Group on PV • North Africa updates on PV ? Tunisia: ? Algeria ? Morocco
Speaker(s)
WHO 3S Initiative: From Pilot to Programme – What Happens Beyond
Shanthi Pal, DrSc, MPharm
WHO, Switzerland
Group Lead, Medicines Safety, Safety & Vigilance
Sarrah Kastalli
Centre National de Pharmacovigilance, Tunisia
North Africa updates on PV: Algeria
Nadjat LOUMI-MEDEDJEL
Centre National De Pharmacovigilance et De Matériovigilance (CNPM), Algeria
Directrice Générale
North Africa updates on PV: Morocco
Rachida Soulaymani-Benchei
Centre Anti Poison Et De Pharmacovigilance Du Maroc, WHO Collaborative Center, Morocco
Director
Have an account?